United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85534-0009_559f2fb7-7b06-ee1a-e063-6394a90a580e
- Product NDC
- 85534-0009
- Form
- TABLET
- Composition / generic term
- Gabapentin
- Labeler
- HAWAII REPACK, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160204
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (85534-0009-0) · 85534-0009-0
- 60 TABLET in 1 BOTTLE (85534-0009-1) · 85534-0009-1
- 90 TABLET in 1 BOTTLE (85534-0009-2) · 85534-0009-2
- 120 TABLET in 1 BOTTLE (85534-0009-3) · 85534-0009-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →